David Schmidt - 14 Aug 2024 Form 4 Insider Report for Astrana Health, Inc. (ASTH)

Role
Director
Signature
/s/ John Vong, as Attorney-in-Fact
Issuer symbol
ASTH
Transactions as of
14 Aug 2024
Net transactions value
-$485,382
Form type
4
Filing time
16 Aug 2024, 16:15:10 UTC
Previous filing
14 Aug 2024
Next filing
13 Jun 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ASTH Common Stock Options Exercise $168,850 +11,000 +118% $15.35* 20,314 14 Aug 2024 Direct
transaction ASTH Common Stock Options Exercise $62,760 +3,409 +17% $18.41* 23,723 14 Aug 2024 Direct
transaction ASTH Common Stock Disposed to Issuer $716,992 -14,409 -61% $49.76 9,314 16 Aug 2024 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ASTH Stock Option (right to buy) Options Exercise $0 -11,000 -100% $0.000000* 0 14 Aug 2024 Common Stock 11,000 $15.35 Direct F3
transaction ASTH Stock Option (right to buy) Options Exercise $0 -3,409 -100% $0.000000* 0 14 Aug 2024 Common Stock 3,409 $18.41 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were repurchased by the Issuer.
F2 Includes 5,750 shares of restricted stock, which will vest on December 9, 2024, and 3,564 shares of restricted stock, which will vest on the earlier of August 13, 2025 or the date of the Issuer's 2025 annual meeting of stockholders.
F3 These stock options were fully vested and exercisable.